Mindblown: a blog about philosophy.

Sonida Senior Living reported promising results in its Q3 2023 earnings call, highlighting accelerated increases in both occupancy and rate. The company experienced a year-over-year margin improvement of nearly 600 basis points and a portfolio occupancy of 84.9%. Sonida’s leadership is focusing on three primary drivers of value creation: enhancing portfolio performance, strengthening the balance […]

Inpixon, a leading indoor data company, has announced definitive merger agreements with XTI Aircraft and Damon Motors during a recent business update presentation. The company plans to rebrand as XTI Aerospace post-merger, focusing on the TriFan 600 aircraft development, besides continuing its real-time location system products. Over 700 conditional pre-orders for the TriFan 600, representing […]

AST SpaceMobile, during their Q3 2023 earnings call, revealed significant strides in their space-based 5G capabilities, achieving 40 megabit per second data rates in their testing program. The company also emphasized its progress towards launching its first five satellites in Q1 2024, with manufacturing well underway in Midland. Key takeaways from the call include: AST […]

Inpixon, a leading indoor data company, has announced definitive merger agreements with XTI Aircraft and Damon Motors during a recent business update presentation. The company plans to rebrand as XTI Aerospace post-merger, focusing on the TriFan 600 aircraft development, besides continuing its real-time location system products. Over 700 conditional pre-orders for the TriFan 600, representing […]

AST SpaceMobile, during their Q3 2023 earnings call, revealed significant strides in their space-based 5G capabilities, achieving 40 megabit per second data rates in their testing program. The company also emphasized its progress towards launching its first five satellites in Q1 2024, with manufacturing well underway in Midland. Key takeaways from the call include: AST […]

Arcturus Therapeutics (NASDAQ:ARCT) provided an update on its Q3 2023 performance and ongoing projects during its recent earnings call. The company’s monovalent COVID-19 vaccine, ARCT-154, is currently under review by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) following favorable Phase 3 study results. Notably, the vaccine demonstrated non-inferiority to Comirnaty and superiority against the Omicron […]

TFF Pharmaceuticals, in its Q3 2023 earnings conference call, provided updates on its Phase 2 studies of TFF VORI and TFF TAC, with initial clinical data expected by year-end. The company, which closed a $5.7 million equity financing in August 2023, anticipates that data from about 10 patients will be sufficient to guide a decision […]

Arcturus Therapeutics (NASDAQ:ARCT) provided an update on its Q3 2023 performance and ongoing projects during its recent earnings call. The company’s monovalent COVID-19 vaccine, ARCT-154, is currently under review by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) following favorable Phase 3 study results. Notably, the vaccine demonstrated non-inferiority to Comirnaty and superiority against the Omicron […]

TFF Pharmaceuticals, in its Q3 2023 earnings conference call, provided updates on its Phase 2 studies of TFF VORI and TFF TAC, with initial clinical data expected by year-end. The company, which closed a $5.7 million equity financing in August 2023, anticipates that data from about 10 patients will be sufficient to guide a decision […]

Energizer (ENR) shares fell 4.5% in early New York trade on Wednesday after at least three brokerage firms downgraded the rating. Morgan Stanley downgraded the rating to Underweight, citing “lower visibility” and increased risk to the top line. RBC Capital Markets characterized the guidance for FY24 as “tepid.” The battery manufacturer previously issued full-year adjusted […]